Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations

Xuening Wang1, George P Studzinski

  • 1Department of Pathology and Laboratory Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, USA.

Insights

Kinase suppressor of ras (KSR) is upregulated during vitamin D-induced HL60 cell differentiation. Inhibiting KSR reduces differentiation, while its expression potentiates it, suggesting KSR

Area of Science:

  • Cellular signaling pathways
  • Molecular mechanisms of differentiation
  • MAPK cascade regulation

Background:

  • Kinase suppressor of ras (KSR) acts upstream in the MEK/ERK MAP kinase cascade.
  • This cascade influences cell growth, survival, and differentiation.
  • 1,25-dihydroxyvitamin D3 (1,25D3) induces differentiation in HL60 cells.

Purpose of the Study:

  • To investigate the role of KSR in 1,25D3-induced HL60 cell differentiation.
  • To determine if KSR activity is essential for the differentiation signaling pathway.

Main Methods:

  • Upregulation of KSR in HL60 cells treated with low-dose 1,25D3.
  • Inhibition of differentiation using antisense oligonucleotides (AS-KSR) against KSR.
  • Assessment of Raf-1 and p90RSK phosphorylation as readouts for MAPK activity.
  • Ectopic expression of wild-type and kinase-inactive KSR constructs.
  • Enzyme assays on immunoprecipitated KSR.

Main Results:

  • AS-KSR inhibited 1,25D3-induced differentiation, an effect lessened at higher 1,25D3 concentrations.
  • Reduced KSR activity correlated with decreased Raf-1 and p90RSK phosphorylation.
  • Ectopic expression of wild-type KSR potentiated differentiation, but kinase-inactive KSR did not.
  • KSR immunoprecipitated from treated cells showed kinase activity against Raf-1, which was blocked by AS-KSR.

Conclusions:

  • KSR is upregulated and plays a role in signaling monocytic differentiation induced by low-dose 1,25D3.
  • KSR kinase activity is required for potentiating 1,25D3-induced differentiation.
  • KSR augments the signal strength through Raf-1 in the MAPK cascade during differentiation.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...